INVESTOR RELATIONS

Stock Information

OTCQB: BRTX
0.00
+0.00
(+0.00%)

BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs relate to the treatment of disc/spine disease and metabolic disorders.

Shares Outstanding:
Approx 11 million
Public Float
(DTC) > Approx. 2.6 million
Auditor
LBB & Associates Ltd., LLP
Legal Counsel:
David Loev – Loev Law Firm, PC
Click Here For Complete Stock Information

Latest News & Press Releases